Healthcare Services

Hepatitis C Testing Market Outlook: Key Drivers and Market Evolution

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Hepatitis C Testing Market Compare Between 2026 And 2030?

The hepatitis c testing market size has shown significant growth in recent years. It is projected to expand from $1.32 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. The increase observed historically can be attributed to the expansion of blood screening programs, the rising prevalence of hepatitis c infections, improved diagnostic awareness, the availability of advanced testing kits, and growth in public health surveillance initiatives.

The hepatitis C testing market is set to experience significant expansion in the upcoming years. It is predicted to reach a value of $1.78 billion by 2030, advancing at a compound annual growth rate (CAGR) of 6.1%. This projected growth stems from factors such as increasing global initiatives for elimination, a heightened demand for point-of-care diagnostics, broader access to molecular testing, rising investments in infectious disease diagnostics, and a greater emphasis on early intervention. Prominent trends anticipated during the forecast period include a surge in the adoption of rapid diagnostic tests, expanding use of molecular testing technologies, a stronger focus on early disease screening, the broadening of high-throughput laboratory testing, and enhanced monitoring of treatment outcomes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

What Key Factors Are Affecting The Hepatitis C Testing Market Demand?

The increasing incidence of hepatitis cases is projected to boost the expansion of the hepatitis C testing market moving forward. Hepatitis C is a viral infection causing liver inflammation, which can lead to significant liver damage if left unaddressed. The rise in hepatitis cases is primarily due to low vaccination rates, leaving many individuals susceptible and accelerating the virus’s transmission. Hepatitis C testing facilitates early virus identification, allowing for prompt treatment to prevent liver damage and severe complications. It also helps identify infected individuals, assisting in preventing further spread and improving disease control. For example, in April 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental body focused on global public health, reported that over 50 million people worldwide live with chronic hepatitis C virus infection, with approximately 1.0 million new infections occurring each year. Thus, the growing prevalence of hepatitis cases is a key driver for the hepatitis C testing market.

What Are The Different Segment Types In The Hepatitis C Testing Market Segment Breakdown?

The hepatitis c testing market covered in this report is segmented –

1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:

1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

What Trends Are Influencing Changes In The Hepatitis C Testing Market?

Leading companies in the hepatitis C testing market are concentrating on developing advanced solutions, such as dual antigen-antibody diagnostic tests, to achieve more effective infection screening and monitoring. These diagnostic tests pinpoint both viral proteins (antigens) and immune response proteins (antibodies), allowing for the identification of both current and prior infections. This dual method provides a comprehensive assessment of the infection’s status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo. This fully automated immunoassay offers the capability to detect both HCV antigens and antibodies simultaneously and independently from a single plasma or serum sample. This advancement supports early diagnosis, assists in patient management, and contributes to India’s national strategy to eliminate hepatitis C through timely and thorough screening.

Who Are The Well-Known Companies In The Hepatitis C Testing Market?

Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

Get The Full Hepatitis C Testing Market Report:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

Which Region Holds The Highest Market Share In The Hepatitis C Testing Market?

North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hepatitis C Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

Viral Hepatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Hepatitis Diagnostic Tests Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Covid 19 Rapid Test Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795